AstraZeneca to Use Compumine Software for Compound Selection | GenomeWeb
NEW YORK (GenomeWeb News) – Data-mining software firm Compumine said last week that it has licensed its Rule Discovery System product to AstraZeneca in Sweden.
 
AstraZeneca will use the technology “to improve compound selection throughout its chemistry domains,” the company said in a statement.
 
Niklas Blomberg, associate director of computational chemistry at AstraZeneca, said in a statement that the software enables his team to predict “important safety and physical-chemical properties of our compounds.”

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.